Current Environment:


Medication Recall

The FDA has issued a medication recall because of bacterial contamination. See more.


Adults with congenital heart disease (ACHD) comprise a growing and increasingly complex population. These patients are living longer, healthier lives than ever before because of advances in surgical and medical care. Many, though, are still at increased risk for a variety of adverse events, both cardiovascular and otherwise.

The term “ACHD” encompasses dozens of diagnoses each with an array of possible treatments that have evolved dramatically over time. This diversity has posed a major challenge to systematic scientific investigation and understanding. Clinical care of ACHD, therefore, often requires consideration of data from related fields or extrapolation from fundamental physiologic principles.

BACHBank, an initiative started in 2012 at Boston Children’s and Brigham and Women’s Hospitals, has been created to address the need to gain a greater scientific understanding of each ACHD patient’s disease process. The Boston Adult Congenital Heart Disease Biobank collects and stores biospecimens to provide a sustainable resource for the scientific investigation of biomarkers in ACHD.

Our main goals are:

  1. to validate the use of clinical biomarkers that have been studied in other patient populations
  2. to facilitate novel biomarker discovery
  3. to improve prospective clinical risk prediction
  4. to define pathophysiologic mechanisms of disease among diverse types of congenital heart disease


Enrolled participants through 1/31/2020: 1,590

The number of participants enrolled in BACHBank through Jan. 31, 2020, is 1,589. 

Please contact us if you have questions about sample availability, collaboration, participation, or any other aspect of BACHBank


Mike Landzberg
Amy Roberts
Boston Children’s Hospital
Department of Cardiology, BACH Service
300 Longwood Avenue
Boston, MA 02115
Phone: 617-355-6508

Alexander (Sasha) Opotowsky
Cincinnati Children's Hospital

Who we are


Research staff

  • Sarah Brainard
  • Catherine Gray
  • Brittani Loukas
  • Taylor Nordan

Scientific Advisory Board

  • Roger Breitbart (Boston Children’s Hospital)
  • Thomas Cappola (Hospital of the University of Pennsylvania)
  • Susan Cheng (Cedars-Sinai Medical Center, Framingham Heart Study)
  • Christopher R. deFilippi (Inova Heart and Vascular Institute)
  • Kim Edgren (patient representative)
  • Sitaram Emani (Boston Children’s Hospital)
  • Tracy Livecchi (patient representative)
  • David Morrow (Brigham and Women’s Hospital, TIMI)
  • Nader Rifai (Boston Children’s Hospital, Laboratory Medicine)
  • Eric Rimm (Harvard T.H. Chan School of Public Health)
  • Gruschen Veldtman (Cincinnati Children’s Hospital)

Publications and projects





1. Opotowsky, A.R., Baraona, F., Owumi, J., Loukas, B., Singh, M.N., Valente, A.M., Wu, F., Cheng, S., Veldtman, G., Rimm, E.B. and Landzberg, M.J., 2016. Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation. Journal of the American Heart Association, 5(1), p.e002706.


Full text:

2. Opotowsky, A.R., Baraona, F.R., Mc Causland, F.R., Loukas, B., Landzberg, E., Landzberg, M.J., Sabbisetti, V. and Waikar, S.S., 2016. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation. Heart, pp.heartjnl-2016.


3. Opotowsky, A.R., Loukas, B., Ellervik, C., Moko, L.E., Singh, M.N., Landzberg, E.I., Rimm, E.B. and Landzberg, M.J., 2016. Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank. World Journal for Pediatric and Congenital Heart Surgery, 7(6), pp.734-743.


Full text:

4. Rajpal, S., Alshawabkeh, L., Almaddah, N., Joyce, C.M., Shafer, K., Gurvitz, M., Waikar, S.S., Mc Causland, F.R., Landzberg, M.J. and Opotowsky, A.R., 2018. Association of albuminuria with major adverse outcomes in adults with congenital heart disease: results from the Boston Adult Congenital Heart Biobank. JAMA Cardiology, 3(4), pp.308-316.


5. Opotowsky AR, Valente AM, Alshawabkeh L, Cheng S, Bradley A, Rimm EB, Landzberg MJ. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. European Heart Journal. 2018 Jul 12;39(34):3253-61.


6. Alshawabkeh L, Rajpal S, Landzberg MJ, Emani S, Ephrem G, Gray C, Singh MN, Wu F, Opotowsky AR. Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank). The American Journal of Cardiology. 2018 Nov 1;122(9):1557-64.


7. Opotowsky, A.R., Carazo, M., Singh, M.N., Dimopoulos, K., Cardona-Estrada, D.A., Elantably, A., Waikar, S.S., Mc Causland, F.R., Veldtman, G., Grewal, J. Gray, C., Loukas B.N., and Rajpal S. 2019. Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank. American heart journal, 214, pp.142-155.


8. Carazo M., Kolodziej M., DeWitt E., Kasparian N., Newburger J., Duarte V., Singh M. and Opotowsky A. 28 April 2020. Prevalence and Prognostic Association of a Clinical Diagnosis of Depression in Adult Congenital Heart Disease: Results of the Boston Adult Congenital Heart Disease Biobank. Journal of the American Heart Association.


Other useful links

The Adult Congenital Heart Disease Learning Center

International Society for Adult Congenital Heart Disease

Clinical Chemistry journal

Adult Congenital Heart Association

Alliance for Adult Research in Congenital Cardiology

CONCOR: Dutch National Registry of Adult Patients with Congenital Heart Disease

The Toronto Heart Centre Biobank Registry

The Bench to Bassinet Program and Congenital Heart Disease Genetic Network Study (CHD GENES)